The entire cell therapy field is experiencing a shift towards allogeneic platforms as the blockbuster potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as reduced cost, production and patient accessibility compared to its autologous counterparts.

Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 5th Allogeneic Cell Therapies Summit returns to Boston this May as the leading industry focused meeting dedicated to accelerating the safety, durability and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.

Across a jam-packed agenda consisting of  4 tracks, 6 Workshops, a NEW Focus Day, and 60+ hours of content, 50+ speakers will lead you and 300+ of your peers in discussions that will help to transform universal cell therapy for patients across the globe.